CA2537489A1 - Vaccines - Google Patents

Vaccines Download PDF

Info

Publication number
CA2537489A1
CA2537489A1 CA002537489A CA2537489A CA2537489A1 CA 2537489 A1 CA2537489 A1 CA 2537489A1 CA 002537489 A CA002537489 A CA 002537489A CA 2537489 A CA2537489 A CA 2537489A CA 2537489 A1 CA2537489 A1 CA 2537489A1
Authority
CA
Canada
Prior art keywords
nucleic acid
muc
protein
acid molecule
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002537489A
Other languages
English (en)
French (fr)
Inventor
Paul Andrew Hamblin
Maria De Los Angeles Rocha Del Cura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2537489A1 publication Critical patent/CA2537489A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001169—Tumor associated carbohydrates
    • A61K39/00117—Mucins, e.g. MUC-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3076—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties
    • C07K16/3092—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties against tumour-associated mucins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6043—Heat shock proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
CA002537489A 2003-09-15 2004-09-13 Vaccines Abandoned CA2537489A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0321614.0 2003-09-15
GBGB0321614.0A GB0321614D0 (en) 2003-09-15 2003-09-15 Vaccines
PCT/EP2004/010323 WO2005025612A1 (en) 2003-09-15 2004-09-13 Vaccines

Publications (1)

Publication Number Publication Date
CA2537489A1 true CA2537489A1 (en) 2005-03-24

Family

ID=29227138

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002537489A Abandoned CA2537489A1 (en) 2003-09-15 2004-09-13 Vaccines

Country Status (6)

Country Link
US (1) US20070042047A1 (https=)
EP (1) EP1663301A1 (https=)
JP (1) JP2007505601A (https=)
CA (1) CA2537489A1 (https=)
GB (1) GB0321614D0 (https=)
WO (1) WO2005025612A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0304634D0 (en) * 2003-02-28 2003-04-02 Glaxo Group Ltd Vaccines
WO2007038083A2 (en) 2005-09-21 2007-04-05 New York University Heat shock proteins from mycobacterium leprae and uses thereof
JP2009544291A (ja) * 2006-07-25 2009-12-17 フォージー ヴァクシンズ ピーティーワイ エルーティーディー ムチン１（ｍｕｃ１）ｔ細胞エピトープ由来ペプチド含有癌ワクチン
CA2665816C (en) 2006-09-21 2016-07-12 Vaxil Biotherapeutics Ltd. Antigen specific multi epitope vaccines
WO2021046364A1 (en) 2019-09-06 2021-03-11 Bio Capital Holdings, LLC Genelight cultures and extracts and applications thereof
CN113480666B (zh) * 2021-08-13 2024-01-26 郑州伊美诺生物技术有限公司 Ca153融合蛋白及其制备方法和ca153检测质控品或校准品

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994029459A1 (en) * 1993-06-04 1994-12-22 Whitehead Institute For Biomedical Research Stress proteins and uses therefor
DK0969862T3 (da) * 1997-02-07 2007-02-12 Merck & Co Inc Syntetisk HIV gag-gener
JP2003510094A (ja) * 1999-09-08 2003-03-18 トランジェーヌ、ソシエテ、アノニム Ｍｕｃ−１由来のペプチド
DE60038622D1 (de) * 1999-10-20 2008-05-29 Univ Johns Hopkins Med Chimäre immunogene zusammensetzungen und dafür kodierende nukleinsäure
EP1257565A4 (en) * 2000-02-01 2005-04-06 Austin Research Inst DERIVED FROM MUCIN-1 ANTIGENE AND ITS USE IN IMMUNOTHERAPY
US20050031649A1 (en) * 2003-08-06 2005-02-10 Yongli Yu Recombinant fusion proteins comprising BCG heat shock protein 65 and the epitope of MUC1

Also Published As

Publication number Publication date
WO2005025612A1 (en) 2005-03-24
US20070042047A1 (en) 2007-02-22
EP1663301A1 (en) 2006-06-07
JP2007505601A (ja) 2007-03-15
GB0321614D0 (en) 2003-10-15

Similar Documents

Publication Publication Date Title
Porgador et al. Induction of antitumor immunity using bone marrow-generated dendritic cells
JP3195958B2 (ja) 悪性腫瘍の治療又は予防のための医薬組成物
ES2319286T3 (es) Epitopos inmunogenos de linfocitos t colaboradores de antigenos de tumor humanos y utilizacion de dichos epitopos en metodos inmunoterapeuticos.
US20040241686A1 (en) Her2/neu target antigen and use of same to stimulate an immune response
JP5017238B2 (ja) 葉酸結合タンパク質の改変体による腫瘍免疫の誘導
AU2003240729B2 (en) MUC-1 antigen with reduced number of VNTR repeat units
WO2019101062A1 (zh) 重组疫苗及其应用
US20070042047A1 (en) Vaccines
JP2008528004A (ja) 突然変異癌タンパク質抗原およびカルレティキュリンをコードするプラスミドを用いる抗癌ｄｎａワクチン
WO1997011669A2 (en) Mhc-class ii restricted melanoma antigens and their use in therapeutic methods
US20060147458A1 (en) Vaccines
US20040191761A1 (en) Modified adenoviral E1A constructs and methods of use thereof
US20060062798A1 (en) Vaccines
EP2852611B1 (en) Novel melanoma antigen peptide and uses thereof
US8921534B2 (en) Enhancement of the immune response using CD36-binding domain
Virus-Specific Adenovirus-Transduced Dendritic Cells
WO2007013352A1 (ja) Hla-a24分子結合性副甲状腺ホルモン関連蛋白由来ペプチドを含有する医薬組成物

Legal Events

Date Code Title Description
FZDE Discontinued